LCD L40272 (Notice Ends 08/09/2026): MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis — WPS
Policy LCD-L40272 · Clinical Laboratory
New MolDX biomarker LCD for MASLD/MASH liver disease effective Aug 2026.